Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Obesity and HLA in multiple sclerosis: Weighty matters.
[Hypomyelination with atrophy of the basal ganglia and cerebellum. Contribution of two new cases to a recently reported entity].
Assessment set for evaluation of clinical outcomes in multiple sclerosis: psychometric properties.
A Psychometric Validation of Two Brief Measures to Assess Palliative Need in Patients Severely Affected by Multiple Sclerosis.
Experimental and therapeutic opportunities for stem cells in multiple sclerosis.
Multiple sclerosis: Managing patients in primary care.
[Cognitive disorders in multiple sclerosis: correlations between neuropsychological, neurophysiological and neuroimaging characteristics.]
Seronegative NMO: A sensitive AQP4 antibody test clarifies clinical features and next challenges.
Assessing the Correlation between Grey and White Matter Damage with Motor and Cognitive Impairment in Multiple Sclerosis Patients.
Redox processes in neurodegenerative disease involving reactive oxygen species.
Quantitative assessment of finger motor impairment in multiple sclerosis.
Protein kinase C polymorphisms and vitamin D levels in multiple sclerosis.
Nonlinear dynamical structure of sway path during standing in patients with multiple sclerosis and in healthy controls is affected by changes in sensory input and cognitive load.
Monitoring technology for wheelchair users with advanced multiple sclerosis.
Primary CNS lymphoma masquerading as tumefactive demyelination.
Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis.
Long-term endurance exercise improves aerobic capacity in patients with relapsing-remitting Multiple Sclerosis: Impact of baseline fatigue.
The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania.
New and emerging immune-targeted drugs for the treatment of multiple sclerosis.
Dysfunction of neuronal calcium signalling in neuroinflammation and neurodegeneration.
Intrathecal baclofen in multiple sclerosis.
Melatonin treatment improves primary progressive multiple sclerosis: a case report.
Emotional Intelligence (EI) of Patients with Multiple Sclerosis (MS).
Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound.
Handling changes in MRI acquisition parameters in modeling whole brain lesion volume and atrophy data in multiple sclerosis subjects: Comparison of linear mixed-effect models.

Pages